Mats Lundgren

Senior Executive

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
2
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity May 13, 2022 – Jul 20, 2026

Mats Lundgren reported 6 transactions between May 13, 2022 and Jul 20, 2026. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
527.6K SEK
6 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
6
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought Abera Bioscience AB shares worth 335,848 SEK between May 12, 2022 and May 18, 2022

Cluster buying

3 different insiders made 10 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

3 insiders bought Abera Bioscience AB shares worth 335,848 SEK between May 12, 2022 and May 18, 2022
Date Insider Transaction Shares Price Value Filing
May 12, 2022 Cristina Glad SACQ Acquisition 6,000 7.98 SEK 47,880 SEK FI filing ↗
May 13, 2022 Mats Lundgren SACQ Acquisition 7,000 8.02 SEK 56,140 SEK FI filing ↗
May 13, 2022 Mats Lundgren SACQ Acquisition 6,000 8.01 SEK 48,060 SEK FI filing ↗
May 13, 2022 Anders Ericsson SACQ Acquisition 2,000 7.93 SEK 15,860 SEK FI filing ↗
May 13, 2022 Anders Ericsson SACQ Acquisition 2,000 7.93 SEK 15,860 SEK FI filing ↗
May 16, 2022 Mats Lundgren SACQ Acquisition 6,535 7.90 SEK 51,627 SEK FI filing ↗
May 16, 2022 Anders Ericsson SACQ Acquisition 6,000 8.20 SEK 49,200 SEK FI filing ↗
May 17, 2022 Mats Lundgren SACQ Acquisition 856 8.29 SEK 7,096 SEK FI filing ↗
May 17, 2022 Anders Ericsson SACQ Acquisition 878 8.50 SEK 7,463 SEK FI filing ↗
May 18, 2022 Mats Lundgren SACQ Acquisition 3,823 9.59 SEK 36,663 SEK FI filing ↗

Total of the rows above: 335,848 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 6 most recent rows are grouped into 5 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Abera Bioscience AB SACQ Acquisition 40,000 shares 328.0K SEK at 8.20 SEK FI filing ↗
  2. Abera Bioscience AB SACQ Acquisition 3,823 shares 36.7K SEK at 9.59 SEK FI filing ↗
  3. Abera Bioscience AB SACQ Acquisition 856 shares 7.1K SEK at 8.29 SEK FI filing ↗
  4. Abera Bioscience AB SACQ Acquisition 6,535 shares 51.6K SEK at 7.90 SEK FI filing ↗
  5. Abera Bioscience AB SACQ Acquisition × 2 13,000 shares 104.2K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    6,000 8.01 SEK 48.1K SEK FI filing ↗
    7,000 8.02 SEK 56.1K SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Abera Bioscience AB SE0015245097 Abera Bioscience 20,391 — — FI marknadssok.fi.se ↗
Abera Bioscience AB SE0014704763 Spotlight Group 43,823 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Mats Lundgren reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.